Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
General Oncology
Diet/Physical Activity Intervention Not More Effective Than Self-Directed Programs for Weight Loss in ALL Survivors
Results of a study comparing weight loss success of a diet and physical activity intervention with self-directed weight loss among ALL survivors are presented at 2021 ASCO Annual Meeting.
A Geriatric Assessment Report Improves Oncologist-Patient Communication on Functional Status and Physical Performance
Results of a secondary analysis on oncology-patient communications regarding FS and PP concerns were presented at the 2021 ASCO Annual Meeting.
Electronic Monitoring May Improve Symptom Management in Cancer Patients Receiving Chemotherapy
An electronic monitoring system improved physical well-being and self-efficacy scores.
Chronic Myeloid Leukemia: What Your Patients Need to Know
Chronic myeloid leukemia (CML) can be painful and life-threatening if it is not caught in time. How can you educate patients with symptoms or who are newly diagnosed about the detection, symptoms, risk factors, and treatment of CML?
Age and Race May Determine Whether Cancer Patients Access Their Electronic Health Records
Black cancer patients were 44% less likely than White patients to enroll in a portal that provides access to electronic health records.
Expanding Medicaid Eligibility May Improve Survival in Patients With Cancer
Patients living in states with lower eligibility limits had worse survival rates, regardless of cancer stage at diagnosis.
Immunogenicity and Safety of the Pfizer-BioNTech COVID-19 Vaccine in Patients With Cancer
This study evaluated the efficacy of the BNT162b2 vaccine in patients with solid tumors or hematologic cancers compared with healthy participants.
Multiple Myeloma: What Your Patients Need to Know
Multiple myeloma is an uncommon form of cancer, and one that may not produce symptoms right away. Because of this, patients with higher risk due to family history, exposure, or other reasons may need more education about it. How can you explain multiple myeloma to your patients?
Pandemic Caused Cancer Screening Deficits in 2020
Results of a retrospective cohort study shows the impact of COVID-19 pandemic on screening rates for breast, prostate, and colorectal cancer.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...